Lucence Diagnostics is a California-based precision oncology company developing liquid biopsy tests for disease detection and personalized treatment.
Lucence Diagnostics is a genomicCalifornia-based medicineprecision oncology company guidingdeveloping cancerliquid carebiopsy acrosstests diverse patientfor jtheirneysdisease withdetection world-leadingand profilingpersonalized technologytreatment.
Founded in April 2016 and headquartered in Palo Alto, California, Lucence Diagnostics is a company in the oncology field dedicated to advancing cancer care. Lucence develops non-invasive liquid biopsy tests designed to detect cancer and suggest appropriate treatment. LiquidHALLMARK® is the company's flagship product, operating on Lucence's trademarked, amplicon-based sequencing technology.
Lucence Diagnostics is a California-based precision oncology company developing liquid biopsy tests for disease detection and personalized treatment.
Lucence is a genomic medicine company guiding cancer care across diverse patient jtheirneys with world-leading profiling technology.